Highlighting Key Data from the CHERISH and SHINE Studies

Opinion
Video

Longitudinal trends in hospitalization rates in patients with later-onset SMA (SMA) treated with nusinersen up to 4.5 years are discussed. Results from the CHERISH and SHINE studies are discussed.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert is featured in this series.
2 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.